Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Kakkar

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|September 4, 2008
Improving clinical outcomes for patients with cancer-associated thrombosisAjay Kakkar
British Journal of Hospital Medicine (London, England : 2005)|July 9, 2009
Venous thromboembolism: a UK perspectiveAjay Kakkar
Cancer Biology & Therapy|November 21, 2013
Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cellsYunliang Chen, Michael Scully, Gloria Petralia, et al.
Thrombosis and Haemostasis|April 11, 2013
Perturbation of the heparin/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K/Akt and MAPK/ERK signallingYunliang Chen, Michael Scully, Gloria Dawson, et al.
Thrombosis and Haemostasis|July 15, 2016
Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER IISamuel Z Goldhaber, Sebastian Schellong, Ajay Kakkar, et al.
Rambam Maimonides Medical Journal|November 12, 2014
Implementing thrombosis guidelines in cancer patients: a reviewDominique Farge-Bancel, Henri Bounameaux, Benjamin Brenner, et al.
Thrombosis and Haemostasis|December 5, 2017
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER IISamuel Z Goldhaber, Sam Schulman, Henry Eriksson, et al.
Vascular Medicine (London, England)|November 4, 2016
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™Samuel Z Goldhaber, Henry Eriksson, Ajay Kakkar, et al.
Thrombosis Research|February 3, 2024
Incidence and risk factors of post-thrombotic syndrome in patients with isolated calf vein thrombosis. Findings from the GARFIELD-VTE registryPaolo Prandoni, Sylvia Haas, Meg Fluharty, et al.
The Lancet. Oncology|October 14, 2016
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Henri Bounameaux, Benjamin Brenner, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|September 4, 2008
Improving clinical outcomes for patients with cancer-associated thrombosisAjay Kakkar
British Journal of Hospital Medicine (London, England : 2005)|July 9, 2009
Venous thromboembolism: a UK perspectiveAjay Kakkar
Cancer Biology & Therapy|November 21, 2013
Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cellsYunliang Chen, Michael Scully, Gloria Petralia, et al.
Thrombosis and Haemostasis|April 11, 2013
Perturbation of the heparin/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K/Akt and MAPK/ERK signallingYunliang Chen, Michael Scully, Gloria Dawson, et al.
Thrombosis and Haemostasis|July 15, 2016
Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER IISamuel Z Goldhaber, Sebastian Schellong, Ajay Kakkar, et al.
Rambam Maimonides Medical Journal|November 12, 2014
Implementing thrombosis guidelines in cancer patients: a reviewDominique Farge-Bancel, Henri Bounameaux, Benjamin Brenner, et al.
Thrombosis and Haemostasis|December 5, 2017
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER IISamuel Z Goldhaber, Sam Schulman, Henry Eriksson, et al.
Vascular Medicine (London, England)|November 4, 2016
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™Samuel Z Goldhaber, Henry Eriksson, Ajay Kakkar, et al.
Thrombosis Research|February 3, 2024
Incidence and risk factors of post-thrombotic syndrome in patients with isolated calf vein thrombosis. Findings from the GARFIELD-VTE registryPaolo Prandoni, Sylvia Haas, Meg Fluharty, et al.
The Lancet. Oncology|October 14, 2016
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Henri Bounameaux, Benjamin Brenner, et al.
Pageof 3